These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
484 related articles for article (PubMed ID: 27025546)
1. Smart surface coating of drug nanoparticles with cross-linkable polyethylene glycol for bio-responsive and highly efficient drug delivery. Wei W; Zhang X; Chen X; Zhou M; Xu R; Zhang X Nanoscale; 2016 Apr; 8(15):8118-25. PubMed ID: 27025546 [TBL] [Abstract][Full Text] [Related]
2. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity. Deng L; Dong H; Dong A; Zhang J Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):107-17. PubMed ID: 26515259 [TBL] [Abstract][Full Text] [Related]
3. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release. Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840 [TBL] [Abstract][Full Text] [Related]
4. Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis. Yu C; Zhou M; Zhang X; Wei W; Chen X; Zhang X Nanoscale; 2015 Mar; 7(13):5683-90. PubMed ID: 25740312 [TBL] [Abstract][Full Text] [Related]
5. Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle. Qin Y; Chen J; Bi Y; Xu X; Zhou H; Gao J; Hu Y; Zhao Y; Chai Z Acta Biomater; 2015 Apr; 17():201-9. PubMed ID: 25644449 [TBL] [Abstract][Full Text] [Related]
6. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo. Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887 [TBL] [Abstract][Full Text] [Related]
7. Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation. Qiu X; Cao K; Lin T; Chen W; Yuan A; Wu J; Hu Y; Guo H Int J Nanomedicine; 2017; 12():7365-7374. PubMed ID: 29066888 [TBL] [Abstract][Full Text] [Related]
8. Polyethylene glycol-conjugated chondroitin sulfate A derivative nanoparticles for tumor-targeted delivery of anticancer drugs. Lee JY; Park JH; Lee JJ; Lee SY; Chung SJ; Cho HJ; Kim DD Carbohydr Polym; 2016 Oct; 151():68-77. PubMed ID: 27474544 [TBL] [Abstract][Full Text] [Related]
9. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer. Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487 [TBL] [Abstract][Full Text] [Related]
10. Folate-decorated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting delivery: optimization and in vivo antitumor activity. Zhang C; Zhang Z; Zhao L Drug Deliv; 2016 Jun; 23(5):1830-7. PubMed ID: 26652055 [TBL] [Abstract][Full Text] [Related]
12. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411 [TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy. Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784 [TBL] [Abstract][Full Text] [Related]
14. cRGD-directed, NIR-responsive and robust AuNR/PEG-PCL hybrid nanoparticles for targeted chemotherapy of glioblastoma in vivo. Zhong Y; Wang C; Cheng R; Cheng L; Meng F; Liu Z; Zhong Z J Control Release; 2014 Dec; 195():63-71. PubMed ID: 25108151 [TBL] [Abstract][Full Text] [Related]
15. IONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy. Fu X; Wang X; Zhou S; Zhang Y Int J Nanomedicine; 2017; 12():3751-3766. PubMed ID: 28553112 [TBL] [Abstract][Full Text] [Related]
16. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation. Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802 [TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers. Elbialy NS; Fathy MM; Khalil WM Phys Med; 2014 Nov; 30(7):843-8. PubMed ID: 24950615 [TBL] [Abstract][Full Text] [Related]
18. Core cross-linked poly(ethylene glycol)-graft-Dextran nanoparticles for reduction and pH dual responsive intracellular drug delivery. Lian H; Du Y; Chen X; Duan L; Gao G; Xiao C; Zhuang X J Colloid Interface Sci; 2017 Jun; 496():201-210. PubMed ID: 28232293 [TBL] [Abstract][Full Text] [Related]
19. Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery. Li C; Yang D; Ma P; Chen Y; Wu Y; Hou Z; Dai Y; Zhao J; Sui C; Lin J Small; 2013 Dec; 9(24):4150-9. PubMed ID: 23843254 [TBL] [Abstract][Full Text] [Related]
20. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery. Tam YT; To KK; Chow AH Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]